Biology Reference
In-Depth Information
57. Lopez-Jaramillo P, Gonzalez MC, Palmer RM, Moncada S. (1990) The crucial role of phys-
iological Ca
2+
concentrations in the production of endothelial nitric oxide and the control of
vascular tone. Br J Pharmacol 101:489-93.
58. Luo X, Zheng W, Yan M, Lee MG, Muallem S. (1999) Multiple functional P2X and P2Y
receptors in the luminal and basolateral membranes of pancreatic duct cells. Am J Physiol
277:C205-15.
59. Mattsson G. (2005) The endothelial cells in islets of Langerhans. Ups J Med Sci 110:1-15.
60. Mattsson G, Carlsson PO, Olausson K, Jansson L. (2002) Histological markers for
endothelial cells in endogenous and transplanted rodent pancreatic islets. Pancreatology 2:
155-62.
61. McCullough WT, Collins DM, Ellsworth ML. (1997) Arteriolar responses to extracellular
ATP in striated muscle. Am J Physiol 272:H1886-91.
62. McGahren ED, Beach JM, Duling BR. (1998) Capillaries demonstrate changes in membrane
potential in response to pharmacological stimuli. Am J Physiol 274:H60-5.
63. Moccia F, Baruffi S, Spaggiari S, et al. (2001) P2y1 and P2y2 receptor-operated Ca2+ signals
in primary cultures of cardiac microvascular endothelial cells. Microvasc Res 61:240-52.
64. Morato M, Sousa T, Albino-Teixeira A. (2008) Purinergic receptors in the splanchnic
circulation. Purinergic Signal 4:267-85.
65. Nikolova G, Jabs N, Konstantinova I, et al. (2006) The vascular basement membrane: a niche
for insulin gene expression and
β
cell proliferation. Dev Cell 10:397-405.
66. Noble MD, Liddle RA. (2005) Neurohormonal control of exocrine pancreatic secretion. Curr
Opin Gastroenterol 21:531-7.
67. Nordquist L, Lai EY, Sjoquist M, Jansson L, Persson AE. (2008) C-peptide constricts pan-
creatic islet arterioles in diabetic, but not normoglycaemic mice. Diabetes Metab Res Rev
24:165-8.
68. Novak I. (2008) Purinergic receptors in the endocrine and exocrine pancreas. Purinergic
Signal 4:237-53.
69. Nyman LR, Wells KS, Head WS, et al. (2008) Real-time, multidimensional in vivo imaging
used to investigate blood flow in mouse pancreatic islets. J Clin Invest 118:3790-97.
70. Olerud J, Johansson M, Lawler J, Welsh N, Carlsson PO. (2008) Improved vascular engraft-
ment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse
pancreatic islets. Diabetes 57:1870-7.
71. Olsson R, Carlsson PO. (2005) Better vascular engraftment and function in pancreatic islets
transplanted without prior culture. Diabetologia 48:469-76.
72. Olsson R, Carlsson PO. (2006) The pancreatic islet endothelial cell: emerging roles in islet
function and disease. Int J Biochem Cell Biol 38:710-4.
73. Parr EL, Bowen KM, Lafferty KJ. (1980) Cellular changes in cultured mouse thyroid glands
and islets of Langerhans. Transplantation 30: 135-41.
74. Persson-Sjogren S, Forsgren S, Taljedal IB. (2000) Peptides and other neuronal markers in
transplanted pancreatic islets. Peptides 21:741-52.
75. Petit P, Lajoix AD, Gross R. (2009) P2 purinergic signalling in the pancreatic
β
-cell: control
of insulin secretion and pharmacology. Eur J Pharm Sci 37:67-75.
76. Pittman RN. (2000) Oxygen supply to contracting skeletal muscle at the microcirculatory
level: diffusion vs. convection. Acta Physiol Scand 168:593-602.
77. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. (2001) Participation of cAMP in a
signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol
Cell Physiol 281:C1158-64.
78. Stagner JI, Samols E, Bonner-Weir S. (1988) beta - alpha - delta pancreatic islet cellular
perfusion in dogs. Diabetes 37:1715-21.
79. Surprenant A, North RA. (2009) Signaling at Purinergic P2X Receptors. Annu Rev Physiol
71:333-59.
80. Svensson AM, Ostenson CG, Sandler S, Efendic S, Jansson L. (1994) Inhibition of nitric
oxide synthase by N
G
-nitro-L-arginine causes a preferential decrease in pancreatic islet blood
flow in normal rats and spontaneously diabetic GK rats. Endocrinology 135:849-53.
Search WWH ::
Custom Search